COVID-19 Vaccine Acceptance Increased Worldwide

COVID-19 Vaccine Hesitancy vs. Acceptance: COVID-19 vaccine acceptance has increased globally, but youngsters are hesitant about COVID-19 boosters.

COVID-19 vaccine acceptance has increased all over the world. However, young people are hesitant about taking COVID-19 boosters.

The global acceptance of COVID-19 vaccines increased from 75.2 percent in 2021 to 79.1 percent in 2022, according to a survey in 23 countries (including India) that represent more than 60 percent of the world's population.

COVID-10 Vaccine Hesitancy Among Young People

The willingness of parents to vaccinate their children also rose slightly, from 67.6 percent in 2021 to 69.5 percent in 2022.

COVID-19 Vaccine: Myths and Facts
Debunking several misconceptions or myths that have surfaced regarding covid vaccination is important and focus on the facts related to COVID-19 vaccines.

‘Let's overcome vaccine hesitancy and get a COVID-19 booster shot as soon as possible to survive and stay away from deadly infections.’
Read More..

However, vaccine acceptance decreased in eight countries and almost one in eight vaccinated respondents, particularly younger men and women, were hesitant about receiving a booster dose, according to the study published in the journal Nature Medicine.

Worryingly, almost one in eight (12.1 percent) vaccinated respondents were hesitant about booster doses. This hesitancy was higher among the younger age groups (18-29).

Led by the Barcelona Institute for Global Health (ISGlobal) andThe City University of New York's Graduate School of Public Health and Health Policy, the study underlines a wide variability among countries and the need for tailored communication strategies in addressing vaccine hesitancy.

Why is COVID-19 Booster Dose Necessary

"The pandemic is not over, and authorities must urgently address vaccine hesitancy and resistance as part of their COVID-19 prevention and mitigation strategy," says Jeffrey V. Lazarus, Head of the Health Systems Research Group at ISGlobal.

Second Dose of COVID-19 Vaccine Linked to Heart Inflammation in Males
The incidence of mRNA vaccine-associated myopericarditis was higher in boys between 12 and 20 years after the second dose of the COVID-19 vaccine.

The 23 highly-populated countries that were hit hard by the pandemic part of the study were Brazil, Canada, China, Ecuador, France, Germany, Ghana, India, Italy, Kenya, Mexico, Nigeria, Peru, Poland, Russia, Singapore, South Africa, South Korea, Spain, Sweden, Turkey, the UK and the US.

The data reported here correspond to the third survey conducted between June and July 2022.

Intranasal COVID-19 Vaccine Works Against COVID-19 Variants
Although India has approved intranasal COVID vaccines in recent months, the road to formulating successful intranasal vaccines is not an easy one.

Of the 23,000 respondents, 79.1 percent were willing to accept vaccination. The finding represented an increase of 5.2 percent from June 2021.

However, eight countries observed increased hesitancy (from 1 percent in the UK to 21.1 percent in South Africa).

Acceptance of COVID-19 Vaccines Increased Globally
How are people accepting the COVID-19 vaccine? The willingness to vaccinate has increased among highly populated countries.

"We must remain vigilant in tracking these data, containing COVID-19 variants and addressing hesitancy, which may challenge future routine COVID-19 immunization programs," said Ayman El-Mohandes, senior author.

The survey also provides new information on COVID-19 treatments received.

Globally, ivermectin was taken with the same frequency as other approved medications, even though the WHO and other agencies do not recommend its use to prevent or treat COVID-19.

Also, almost 4 percent respondents reported paying less attention to new COVID-19 information than before and having less support for vaccine mandates.

"Our results show that public health strategies to enhance booster coverage will need to be more sophisticated and adaptable for each setting and target population," says Lazarus.

Source-IANS